Alex C. Sapir
2023
In 2023, Alex C. Sapir earned a total compensation of $7M as President and Chief Executive Officer at Fulcrum Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $150,000 |
|---|---|
| Option Awards | $6,398,757 |
| Salary | $369,419 |
| Other | $72,420 |
| Total | $6,990,596 |
Sapir received $6.4M in option awards, accounting for 92% of the total pay in 2023.
Sapir also received $150K in non-equity incentive plan, $369.4K in salary and $72.4K in other compensation.
Rankings
In 2023, Alex C. Sapir's compensation ranked 49th out of 2,907 executives tracked by ExecPay. In other words, Sapir earned more than 98.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 49 out of 2,907 | 98th |
Division Manufacturing | 23 out of 1,599 | 99th |
Major group Chemicals And Allied Products | 18 out of 901 | 98th |
Industry group Drugs | 17 out of 864 | 98th |
Industry Pharmaceutical Preparations | 10 out of 622 | 98th |
Source: SEC filing on April 19, 2024.
Sapir's colleagues
We found five more compensation records of executives who worked with Alex C. Sapir at Fulcrum Therapeutics in 2023.
2023
Curtis Oltmans
Fulcrum Therapeutics
Chief Legal Officer
2023
Mel Hayes
Fulcrum Therapeutics
Executive Vice President, Patient Affairs
2023
Alan Musso
Fulcrum Therapeutics
Chief Financial Officer
2023
Bryan Stuart
Fulcrum Therapeutics
Chief Executive Officer
2023
Robert Gould
Fulcrum Therapeutics